HPLC analysis of quinolinic acid, a NAD biosynthesis intermediate, after fluorescence derivatization in an aqueous matrix

被引:0
作者
Xia, CS [1 ]
Dang, YH [1 ]
Brown, OR [1 ]
机构
[1] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA
关键词
high performance liquid chromatography; quinolinic acid; NAD biosynthesis intermediate; fluorescence derivatization; aqueous matrix;
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Quinolinic acid (a,3-pyridine dicarboxylic acid), a biological intermediate in nicotinamide adenine dinucleotide (NAD) biosynthesis in microbes and mammals and a brain excitotoxin, is not fluorescent nor electrochemically active and its detection sensitivity by UV absorption is comparatively low. Quinolinic acid was successfully derivatized in water-based samples by monodansylcadaverine, a fluorescence tag, and analysed by high-performance liquid chromatography (HPLC). No extraction procedure was needed and quinolinic acid was activated by water-soluble carbodiimide and derivatized under mild conditions. As little as 3 pmol (500 pg) of quinolinic acid in 5 mu l of artificial cerebrospinal fluid sample volume could be derivatized and detected at a signal to noise ratio of 3:1. Thus, detection on a mass; basis by HPLC after fluorescence derivatization is about 300 times as sensitive as direct determination of quinolinic acid by UV absorbance (500 pg vs 150 ng). A variety of activators, fluorescent tags and reaction solvents and conditions were tested but found to be less effective.
引用
收藏
页码:167 / 181
页数:15
相关论文
共 29 条
[1]   REPLICATION OF THE NEUROCHEMICAL CHARACTERISTICS OF HUNTINGTONS-DISEASE BY QUINOLINIC ACID [J].
BEAL, MF ;
KOWALL, NW ;
ELLISON, DW ;
MAZUREK, MF ;
SWARTZ, KJ ;
MARTIN, JB .
NATURE, 1986, 321 (6066) :168-171
[2]   MICRODIALYSIS - THEORY AND APPLICATION [J].
BENVENISTE, H ;
HUTTEMEIER, PC .
PROGRESS IN NEUROBIOLOGY, 1990, 35 (03) :195-215
[3]   QUINOLINIC ACID IN THE CEREBROSPINAL-FLUID OF CHILDREN WITH SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DISEASE - RELATIONSHIPS TO CLINICAL STATUS AND THERAPEUTIC RESPONSE [J].
BROUWERS, P ;
HEYES, MP ;
MOSS, HA ;
WOLTERS, PL ;
POPLACK, DG ;
MARKEY, SP ;
PIZZO, PA .
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (06) :1380-1386
[4]  
BROWN DE, 1995, OPERAT RES COMP SCI, V3, P1
[5]   DETERMINATION OF TRYPTOPHAN AND 10 OF ITS METABOLITES IN A SINGLE ANALYSIS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH MULTIPLE DETECTION [J].
CARUSO, U ;
FOWLER, B ;
MINNITI, G ;
ROMANO, C .
JOURNAL OF CHROMATOGRAPHY A, 1994, 661 (1-2) :101-104
[6]  
Dawson R.M. C., 2002, DATA BIOCH RES
[7]   SEPARATION OF TRYPTOPHAN-METABOLITES BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH AMPEROMETRIC AND FLUORESCENCE DETECTION [J].
ELDERFIELD, AJ ;
TRUSCOTT, RJW ;
GAN, IET ;
SCHIER, GM .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1989, 495 :71-80
[8]   A RADIOENZYMATIC ASSAY FOR QUINOLINIC ACID [J].
FOSTER, AC ;
OKUNO, E ;
BROUGHER, DS ;
SCHWARCZ, R .
ANALYTICAL BIOCHEMISTRY, 1986, 158 (01) :98-103
[9]   SIMULTANEOUS MEASUREMENTS OF TRYPTOPHAN AND ITS METABOLITES, KYNURENINE AND SEROTONIN, IN THE SUPERFICIAL LAYERS OF THE SPINAL DORSAL HORN - A STUDY IN NORMAL AND ARTHRITIC RATS [J].
GODEFROY, F ;
MATSON, WR ;
GAMACHE, PH ;
WEILFUGAZZA, J .
BRAIN RESEARCH, 1990, 526 (01) :169-172
[10]  
GUIDETTI P, 1995, J NEUROCHEM, V65, P2621